Chunghwa Chemical Synthesis & Biotech Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chunghwa Chemical Synthesis & Biotech Co Ltd with three other
companies in this sector in Taiwan:
Syngen Biotech Co Ltd
sales of 1.08 billion Taiwanese Dollars [US$35.28 million]
of which 99%
was Functional Food and Mupirocin),
Savior Lifetec Corp
(1.10 billion Taiwanese Dollars [US$36.07 million]
of which 100%
was Drugs Development, Production and Sales), and
Allied Biotech Corporation
(765.26 million Taiwanese Dollars [US$24.99 million]
of which 53%
was A department).
During the year ended December of 2018, sales at
Chunghwa Chemical Synthesis & Biotech Co Ltd were 1.02 billion Taiwanese Dollars (US$33.29 million).
decrease of 12.7%
versus 2017, when the company's sales were 1.17 billion Taiwanese Dollars.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Chunghwa Chemical Synthesis & Biotech Co Ltd had sales
of 1.04 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 21.1% decline
in Usa, from 630.54 million Taiwanese Dollars to 497.18 million Taiwanese Dollars.
There were also decreases in sales in
Taiwan (down 2.9% to 522.27 million Taiwanese Dollars)